Biotechs find stability despite turbulence, new study finds

In its relatively brief lifetime, the biotechnology industry has swung between exuberance and despondency. In an uncertain environment, the best path is to stay the course, according to a new report from the professional services firm EY.

To stay the course means continuing to invest in new technologies,...